Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others > Other Targets

Other Targets

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC8602 LY311727 Featured
LY 311727 is a specific group II sPLA2 (phospholipase A2 (PLA2)) inhibitor which has been reported to attenuate VEGF-mediated platelet-activating factor (PAF) synthesis in HUVEC and BAEC cells.
More description
DC8697 Terbuthylazine Featured
Terbuthylazine is an inhibitor of acetolactate syntase (ALS), is a selective herbicide.
More description
DC8684 Fenoxaprop-P-ethyl Featured
Fenoxaprop-P-ethyl is a post-emergent phenoxy herbicide of the aryloxyphenoxy propionate group.
More description
DC10569 MDK1088(T.cruzi Inhibitor) Featured
MDK-1088, also known as T.cruzi Inhibitor, is a Trypanosoma cruzi inhibitor. MDK-1088 has CAS#1350920-22-7 . The last 4 digit f CAS# was used in its name.
More description
DC10573 MDK34597 (PI3K inhibitor) Featured
MDK34597 is a PI3K inhibitor.MDK34597 is an analog of PI-103 and acts as a dual PI3K/mTOR Inhibitor.
More description
DC10572 MDK35833(Oct3/4-inducer-1) Featured
MDK35833, also known as Oct3/4-inducer-1, is a potent Oct3/4-inducer.
More description
DC24209 MDK7229(MD2-IN-1) Featured
MDK7229, also known as MD2-IN-1 is a MD2 (Myeloid differentiation protein 2) inhibitor.
More description
DC10570 MDK74978(Multi-kinase inhibitor) Featured
MDK74978, also known as Multi-kinase inhibitor I, is a Multi-kinase inhibitor. MDK74978 has CAS#778274-97-8. The last 5 digit was used in its name.
More description
DC10571 MDK-8582(Hnps-PLA Inhibitor) Featured
MDK-8582, also known as Hnps-PLA Inhibitor, is an nhibitor of human nonpancreatic secretory Phospholipase A (hnps-PLA).
More description
DC10650 MDVN1003 Featured
MDVN1003 is a potent inhibitor of BTK amd PI3K delta.
More description
DC8712 Deoxycorticosterone acetate Featured
Deoxycorticosterone acetate is a steroid hormone produced by the adrenal gland that possesses mineralocorticoid activity and acts as a precursor to aldosterone.
More description
DC8906 Indinavir Featured
Indinavir(MK-639; L735524) is a potent and specific HIV protease inhibitor that appears to have good oral bioavailability.
More description
DC8910 Flunarizine dihydrochloride Featured
Flunarizine is a selective calcium entry blocker.
More description
DC8932 TG003 Featured
TG003 is a potent and ATP-competitive Cdc2-like kinase (Clk) inhibitor with IC50 of 20 nM, 200 nM, and 15 nM for Clk1, Clk2, and Clk4, respectively. No inhibitory effect on Clk3, SRPK1, SRPK2, or PKC.
More description
DC8939 Tolrestat Featured
Tolrestat(AY-27773) is a potent, orally active aldose reductase inhibitor with IC50 value of 35 nM.
More description
DC9375 GPDA Featured
GPDA(Glycylproline p-nitroanilide tosylate) is the substarate of X-Prolyl dipeptidyl-aminopeptidase in the enzyme assay.
More description
DC9460 CHR-6494 Featured
CHR-6494 is a potent and selective Haspin (Haploid Germ Cell-Specific Nuclear Protein Kinase) inhibitor that blocks H3T3ph phosphorylation.
More description
DC9500 Cevimeline (hydrochloride hemihydrate) Featured
Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome.
More description
DC9569 Nefazodone (hydrochloride) Featured
Nefazodone hydrochloride is an antidepressant drug.
More description
DC9651 Ingenol 3-angelate Featured
Ingenol 3-Angelate is a PKC(protein kinase C)activator; anti-cancer drug and an active ingredient in Euphorbia peplus.
More description
DC8979 Stavudine Featured
Stavudine is a nucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.
More description
DC9010 Sasapyrine Featured
Salsalate is a nonsteroidal anti-inflammatory drug (NSAID).
More description
DC20065 PF-06733804 Featured
Trk-IN-3 is a potent pan-Trk inhibitor in cell-based assays with IC50s of 8.4 nM, 6.2 nM and 2.2 nM for TrkA, TrkB and TrkC, respectively. Anti-hyperalgesic effect.
More description
DC20297 6-Hydroxy-DL-DOPA Featured
6-Hydroxy-DL-DOPA is a small-molecule that disrupts with RAD52 oligomerization, inhibits ssDNA binding by RAD52 with IC50 of 1.1 uM and by RAD52 (1 209) with IC50 of 1.6 uM.
More description
DC20857 Calhex-231 Featured
Calhex-231 is a potent negative allosteric modulator of CaSR that blocks calcium-mediated activation with IC50 of 0.39 uM.
More description
DC20945 DC_AC50 Featured
DC_AC50 (DCAC50) is a small molecule that inhibits the human copper chaperones Atox1 and CCS (Kd=6.8 and 8.2 uM), blocks copper trafficking and significantly attenuates cancer cell proliferation.
More description
DC21002 Edelfosine Featured
Edelfosine is a synthetic lysophospholipid analog that selectively inhibits PLC with IC50 of 9.6 uM in fibroblasts and adenocarcinoma cells.
More description
DC20866 CC-671 Featured
CC-671 is a potent, selective, dual TTK (Mps1)/CLK2 inhibitor with IC50 of 5/3 nM, respectively.
More description
DC33031 CRANAD-2 Featured
CRANAD-2 is a difluoroboron-derivatized curcumins as near-infrared probe for in vivo detection of amyloid-beta deposits. Upon interacting with Abeta aggregates, CRANAD-2 undergoes a range of changes, which include a 70-fold fluorescence intensity increase, a 90 nm blue shift (from 805 to 715 nm), and a large increase in quantum yield. Moreover, this probe also shows a high affinity for Abeta aggregates (K(d) = 38.0 nM), a reasonable log P value (log P = 3), considerable stability in serum, and a weak interaction with albumin. After intravenous injection of this probe, 19-month-old Tg2576 mice exhibited significantly higher relative signal than that of the control mice over the same period of time.
More description
DC33238 A286982 Featured
A286982 is an inhibitor that blocks the integrin-ligand interaction between leukocyte function-associated antigen-1 (LFA-1) and intercellular adhesion molecule-1.
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X